QuiaPEG Pharmaceuticals Holding AB Capital Reinvestment Ratio

Latest as of December 2015: 0.38x

QuiaPEG Pharmaceuticals Holding AB capital reinvestment ratio. QuiaPEG Pharmaceuticals Holding AB (QUIA) has a Capital Reinvestment Ratio of 0.38x as of December 2015, meaning it reinvests 0% of its operating cash flow (Skr487.00K) in capital expenditures (Skr184.00K). Check QuiaPEG Pharmaceuticals Holding AB (QUIA) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.38x
Capex / Operating Cash Flow

Operating Cash Flow

Skr487.00K
SEK

Capital Expenditures

Skr184.00K
SEK

Data as of

Dec 2015
Most recent filing

Capital Reinvestment Ratio of QuiaPEG Pharmaceuticals Holding AB (2008–2015)

Capital reinvestment ratio of QuiaPEG Pharmaceuticals Holding AB from 2008 to 2015. This chart tracks QuiaPEG Pharmaceuticals Holding AB's Capital Reinvestment Ratio across 6 annual periods. Also explore QUIA net assets growth trend to track the company's year-over-year net asset growth rate.

QuiaPEG Pharmaceuticals Holding AB Capital Reinvestment Ratio by Year (2008–2015)

QuiaPEG Pharmaceuticals Holding AB capital reinvestment ratio by year from 2008 to 2015. For the full cash flow conversion analysis, see QuiaPEG Pharmaceuticals Holding AB (QUIA) cash conversion ratio.

Year Reinvestment Ratio Operating CF (SEK) Capital Expenditures YoY Change
2015 0.38x Skr487.00K Skr184.00K ▲ +5518.2%
2014 0.01x Skr1.49 Million Skr10.00K ▼ -97.0%
2011 0.22x Skr2.55 Million Skr573.00K ▼ -12.2%
2010 0.26x Skr2.65 Million Skr677.00K ▲ +91.3%
2009 0.13x Skr1.82 Million Skr244.00K ▼ -96.2%
2008 3.53x Skr956.00K Skr3.38 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow